Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19. Leonardi A, Rosani U, Cavarzeran F, Daull P, et al. Allergy 2022;77:298-300.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leonardi A, Rosani U, Cavarzeran F, Daull P, et al. Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19. Allergy 2022;77:298-300.
PMID: 34390598